Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-17

Clinical Trial Update: Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris [Phase 3]

View source ↗

Summary

Phase 3 trial update on fixed combination adapalene 0.1% / benzoyl peroxide 2.5% gel for acne vulgaris evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fixed combination adapalene 0.1% / benzoyl peroxide 2.5% gel (adapalene / benzoyl peroxide)

Snippet

Sponsor: Galderma R&D | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED